乌鸦传媒

<乌鸦传媒 class='mpt-top_cat_title'>Meeting Coverage >

EULAR

<乌鸦传媒>Novel IL-17 Inhibitor Passes Mid-Stage Test in Psoriatic Arthritis

Phase II results suggest drug could outperform existing agents

<乌鸦传媒>Trial Upends Guidelines on Long-Term Steroids in Rheumatoid Arthritis

Vindication for clinicians who ignored official recommendations

<乌鸦传媒>European Docs See Smooth Post-COVID Future in Rheumatology

Many long-term impacts inevitable, but EULAR attendees mostly optimistic

<乌鸦传媒>Sex and the (Not Quite) Single Arthritis Patient

It isn't good for many

<乌鸦传媒>Can Methotrexate Treat Arthritis Before It Becomes Arthritis?

Mainstay drug for RA helpful in disease's earliest stage

<乌鸦传媒>Air Pollution and Illness: It's Not Just the Lungs and Heart Anymore

Expanding range of conditions caused or aggravated by fine particulates

<乌鸦传媒>Secukinumab Shows Promise for Kids With Arthritis

More than 90% responded at week 12, study showed

<乌鸦传媒>COVID Vaccine Safe in Rheumatic Patients

Few disease flares and only two serious adverse events thus far in EULAR registry

<乌鸦传媒>Targeting GM-CSF: A New Approach to COVID?

Risk of death was reduced by 61% in global phase II trial of mavrilimumab

<乌鸦传媒>Personalized Algorithm Helps Guide Rituximab Retreatment

For ANCA-associated vasculitis, fixed retreatment not needed if naive B cells reappear

<乌鸦传媒>Guselkumab Succeeds for TNF Failures in Psoriatic Arthritis

Benefits seen across all domains in phase IIIb trial

<乌鸦传媒>IVIG a Winner for Dermatomyositis

Pivotal phase III trial shows clear efficacy

<乌鸦传媒>Nintedanib Slows Decline in RA-Associated Interstitial Lung Disease

Similar results to original larger trial seen in post-hoc analysis

<乌鸦传媒>Oral JAK 1 Inhibitor Eases Spine Inflammation in Ankylosing Spondylitis

Treatment with filgotinib resulted in significant improvements compared with placebo

<乌鸦传媒>Even Exposure to Passive Smoking Increases Risk of RA

Disease onset was earlier in women exposed to smoky rooms during childhood

<乌鸦传媒>Rituximab a Hazard in RA Patients With COVID

Poor outcomes were fourfold higher among rituximab users than for those on TNF inhibitors

<乌鸦传媒>Gout: Methotrexate May Enhance Pegloticase Response

In small study, uric acid levels were reduced to near undetectable levels in almost 80% of patients

<乌鸦传媒>Psoriatic Arthritis: Outcomes Similar for Cosentyx and Humira

Primary endpoint of superiority for secukinumab over adalimumab not met in a phase IIIb trial

<乌鸦传媒>Voclosporin Beats Standard of Care in Lupus Nephritis

High rates of response seen even among difficult-to-treat Hispanic patients

<乌鸦传媒>Rheumatoid Arthritis: Remission Rates High With Very Early Tx

Highest rates at 6 months seen with abatacept plus methotrexate

<乌鸦传媒>Avacopan Superior to Steroids in ANCA Vasculitis

Greater rates of remission and improved renal function seen with oral C5a receptor antagonist

<乌鸦传媒>Another IL-6 Blocker Succeeds in Rheumatoid Arthritis

Effective in patients with moderately to severely active disease in a phase III trial

<乌鸦传媒>EULAR 2020: What to Expect

Cancelled due to pandemic but extensive menu of virtual learning planned

<乌鸦传媒>Methotrexate Withdrawal: Feasible in Stable RA?

Tofacitinib monotherapy appears to maintain low disease activity

<乌鸦传媒>IL-17a Drug Rescues Many Refractory Psoriatic Arthritis Cases

Disease abated in half of patients receiving secukinumab after failing other biologics

<乌鸦传媒>No Cancer Risk Found With TNF Inhibitors in Psoriatic Arthritis

Expected cancer cases similar to those in general populace, study shows

<乌鸦传媒>Low-Dose Steroid Reduces Hand Pain in Osteoarthritis

Finger pain relieved at 6 weeks with prednisolone therapy

<乌鸦传媒>Sjogren's Oral Drug Fails in Small Trial

More than half of patients developed rashes

<乌鸦传媒>Cardiovascular Risk in RA: Beyond Inflammation?

With adverse lifestyle plus bad genes plus inflammation, 'you unleash hell'

<乌鸦传媒>Weight, Smoking Inhibit RA Remission

Factors differ for women and men, but both relate to lifestyle

<乌鸦传媒>Meds Improve Cardiovascular Risk in RA

Benefits seen for hydroxychloroquine, methotrexate, and tocilizumab

<乌鸦传媒>Tofacitinib Shows MRI Benefits in AS

Improvements seen on MRI for both sacroiliac joints and spine

<乌鸦传媒>Remission Common in Early SpA With Golimumab

Drug-free remission maintained for more than half after at least 12 months

<乌鸦传媒>Stelara Eases Spine Symptoms in PsA

Improvements with ustekinumab maintained for 2 years

<乌鸦传媒>Heart Risk Higher in Sjogren's Patients

PARIS -- Patients with Sjogren's syndrome had more than double the heart attack risk seen in the general population, a researcher reported here.

<乌鸦传媒>Orencia Combo Tops in Early, Severe RA

PARIS -- In a study of patients with poor-prognosis early rheumatoid arthritis, more patients treated with abatacept (Orencia) plus methotrexate were in remission at 1 year than were those on methotrexate alone, a researcher reported here.